Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00046748
Status:
COMPLETED
Last Update Posted:
2017-08-02
First Post:
2002-10-02
Brief Title:
Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-12
Start Date Type:
None
Primary Completion Date:
2004-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-04
Completion Date Type:
ACTUAL
First Submit Date:
2002-10-02
First Submit QC Date:
October 3 2002
Study First Post Date:
2002-10-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-31
Last Update Post Date:
2017-08-02
Last Update Post Date Type:
ACTUAL